Treatment for Alcoholism

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Alcoholism+2 More
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will study whether an adapted version of interpersonal psychotherapy (IPT) is an effective treatment for alcohol use disorder (AUD) in gender minority (GM) individuals. GM individuals experience disproportionately high rates of hazardous drinking and AUD, and there are no evidence-based alcohol interventions for this population. The study will use mixed-methods formative research with an established multi-site longitudinal GM cohort to develop and assess the feasibility of the adapted IPT intervention.

Eligible Conditions
  • Alcoholism
  • Alcohol Use Disorder

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 1 Secondary · Reporting Duration: 9 weeks and 13 weeks

9 weeks
Acceptability - Treatment Acceptability Questionnaire
Feasibility - Completing all study sessions
Week 13
Heavy drinking days

Trial Safety

Safety Progress

1 of 3

Trial Design

0 Treatment Group

20 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 9 weeks and 13 weeks

Who is running the clinical trial?

New York State Psychiatric InstituteLead Sponsor
455 Previous Clinical Trials
148,555 Total Patients Enrolled
17 Trials studying Alcoholism
1,384 Patients Enrolled for Alcoholism
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
710 Previous Clinical Trials
1,170,771 Total Patients Enrolled
370 Trials studying Alcoholism
973,566 Patients Enrolled for Alcoholism
Jeremy D Kidd, MDPrincipal InvestigatorNew York State Psychiatric Institute/Research Foundation for Mental Hygiene, Inc

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have a current diagnosis of alcohol use disorder (AUD).

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 7th, 2021

Last Reviewed: October 4th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References